These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2926453)

  • 1. Normal rat serum cytotoxicity against syngeneic oligodendrocytes. Complement activation and attack in the absence of anti-myelin antibodies.
    Scolding NJ; Morgan BP; Houston A; Campbell AK; Linington C; Compston DA
    J Neurol Sci; 1989 Feb; 89(2-3):289-300. PubMed ID: 2926453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement mediated serum cytotoxicity against oligodendrocytes: a comparison with other cells of the oligodendrocyte-type 2 astrocyte lineage.
    Scolding NJ; Morgan BP; Campbell AK; Compston DA
    J Neurol Sci; 1990 Jul; 97(2-3):155-62. PubMed ID: 2205708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible injury of cultured rat oligodendrocytes by complement.
    Scolding NJ; Houston WA; Morgan BP; Campbell AK; Compston DA
    Immunology; 1989 Aug; 67(4):441-6. PubMed ID: 2767708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical study with an anti-myelin serum. A marker for all glial cells except 'dark' oligodendrocytes.
    Roussel G; Nussbaum JL
    J Neuroimmunol; 1983 Dec; 5(3):209-26. PubMed ID: 6361066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular removal by oligodendrocytes of membrane attack complexes formed by activated complement.
    Scolding NJ; Morgan BP; Houston WA; Linington C; Campbell AK; Compston DA
    Nature; 1989 Jun; 339(6226):620-2. PubMed ID: 2733792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)].
    Taranova NP; Kirchik OS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691
    [No Abstract]   [Full Text] [Related]  

  • 7. Killing of rat glial cells by complement: deficiency of the rat analogue of CD59 is the cause of oligodendrocyte susceptibility to lysis.
    Piddlesden SJ; Morgan BP
    J Neuroimmunol; 1993; 48(2):169-75. PubMed ID: 7693753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Demyelination in brain cell aggregate cultures, induced by a monoclonal antibody against the myelin/oligodendrocyte glycoprotein (MOG).
    Honegger P; Matthieu JM; Lassmann H
    Schweiz Arch Neurol Psychiatr (1985); 1989; 140(1):10-3. PubMed ID: 2467359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum cytotoxicity to oligodendrocytes in multiple sclerosis and controls: assessment by 51Cr release assay.
    Suzumura A; Lisak RP; Silberberg DH
    J Neuroimmunol; 1986 Apr; 11(2):137-47. PubMed ID: 3949965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to oligodendroglia in patients with multiple sclerosis.
    Abramsky O; Lisak RP; Silberberg DH; Pleasure DE
    N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myelin-oligodendrocyte glycoprotein (MOG) is a surface marker of oligodendrocyte maturation.
    Scolding NJ; Frith S; Linington C; Morgan BP; Campbell AK; Compston DA
    J Neuroimmunol; 1989 May; 22(3):169-76. PubMed ID: 2649509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies directed against rubella virus induce demyelination in aggregating rat brain cell cultures.
    Besson Duvanel C; Honegger P; Matthieu JM
    J Neurosci Res; 2001 Sep; 65(5):446-54. PubMed ID: 11536329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of oligodendrocyte interaction with normal human serum--defining the role of complement.
    Zajicek J; Wing MG; Lachmann PJ; Compston DA
    J Neurol Sci; 1992 Mar; 108(1):65-72. PubMed ID: 1624954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bystander mechanism for complement-initiated early oligodendrocyte injury in neuromyelitis optica.
    Tradtrantip L; Yao X; Su T; Smith AJ; Verkman AS
    Acta Neuropathol; 2017 Jul; 134(1):35-44. PubMed ID: 28567523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-heat shock protein 90beta antibodies decrease pre-oligodendrocyte population in perinatal and adult cell cultures. Implications for remyelination in multiple sclerosis.
    Cid C; Alvarez-Cermeño JC; Salinas M; Alcázar A
    J Neurochem; 2005 Oct; 95(2):349-60. PubMed ID: 16135098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies.
    Vanguri P; Koski CL; Silverman B; Shin ML
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3290-4. PubMed ID: 6954480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
    Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental allergic encephalomyelitis: serum immunoglobulin binds to myelin and oligodendrocytes in cultured tissue: ultrastructural-immunoperoxidase observations.
    Johnson AB; Raine CS; Bornstein MB
    Lab Invest; 1979 May; 40(5):568-75. PubMed ID: 374865
    [No Abstract]   [Full Text] [Related]  

  • 19. The initial events in myelin synthesis: orientation of proteolipid protein in the plasma membrane of cultured oligodendrocytes.
    Hudson LD; Friedrich VL; Behar T; Dubois-Dalcq M; Lazzarini RA
    J Cell Biol; 1989 Aug; 109(2):717-27. PubMed ID: 2474554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum-mediated oligodendrocyte cytotoxicity in multiple sclerosis patients and controls.
    Hirayama M; Lisak RP; Silberberg DH
    Neurology; 1986 Feb; 36(2):276-8. PubMed ID: 3945400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.